MEK inhibitor (unspecified)
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for MEK inhibitor (unspecified), covering 2017-03-07 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: MEK Inhibitor and a PDL1 Inhibitor Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma [Phase 1, Phase 2]